AKI Prevention and Early Intervention in Patients Undergoing VAD Placement

NACompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

April 11, 2017

Primary Completion Date

February 17, 2019

Study Completion Date

February 17, 2019

Conditions
Kidney Injury
Interventions
OTHER

Clinical Recommendations

"The investigators will provide clinical recommendations to the subject's primary care provider. These will be in regards to the following:~1. Avoidance of potentially nephrotoxic medications.~2. Optimizing volume status (avoidance of volume overload or depletion)~3. Optimizing electrolytes and acid-base status~4. Minimizing IV contrast exposure when appropriate~5. Treating severe anemia~6. Optimization of hemodynamics (Mean arterial BP\>65mmHg)"

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03236831 - AKI Prevention and Early Intervention in Patients Undergoing VAD Placement | Biotech Hunter | Biotech Hunter